Hydroperoxides in plasma are reduced by intensified insulin treatment: A randomized controlled study of IDDM patients with microalbuminuria

Diabetes Care

Volumn 21, Issue 8, 1998, Pages 1295-1300

  Berg, Tore Julsrud ^a   Nourooz Zadeh, Jaffar ^b   Wolff, Simon P ^b   Tritschler, Hans J ^c   Bangstad, Hans Jacob ^a   Hanssen, Kristian F ^a  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ASTA MEDICA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HYDROPEROXIDE; INSULIN; REACTIVE OXYGEN METABOLITE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INFUSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; MICROALBUMINURIA; OXIDATIVE STRESS; PEROXIDATION; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031881006     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.8.1295     Document Type: Article

References (41)

1. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
2. Wolff SP: The potential role of oxidative stress in the diabetic complications: novel implications for theory and therapy. In Diabetic Complications: Scientific and Clinical Aspects. Edinburgh, U.K., Churchill Living-stone, 1987, p. 167-220
3. Wolff SP, Dean RT: Glucose autoxidation and protein modification: the potential role of autoxidative glycosylation in diabetes. Biochem J 245:243-250, 1987
4. Hunt JV, Dean RT, Wolff SP: Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205-212, 1988
5. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:321-326, 1992
6. Ha H, Yoon SJ, Kim KH: High glucose can induce lipid peroxidation in the isolated rat glomeruli. Kidney Int 46:1620-1626, 1994
7. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010-1014, 1994
8. Jenkins AJ, Klein RL, Chassereau CN, Hermayer KL, Lopes-Virella MF: LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation. Diabetes 45:762-767, 1996
9. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunction in diabetic rats by treatment with d-α-tocopherol. J Am Soc Nephrol 8:426-435, 1997
10. Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T, Kojiima Y, Ohsaki Y, Ide H, Tsuji M, Kondo T, Kawakami Y: Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr 63:765-768, 1985
11. Knöbl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Müller M: Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1045-1050, 1993
12. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knöbl P, Petschman P, Prager R, Schnack C, Schernthaner G, Müller MM: Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469-475, 1995
13. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102:63-67, 1993
14. McGrath LT, Brennan GM, Donnelly JP, Johnston GD, Hayes JR, McVeigh GE: Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus. Atherosclerosis 121:275-283, 1996
15. Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, Clerc M, Gin H: Short-term insulin therapy and normoglycemia: effects on erythrocyte lipid peroxidation in NIDDM patients. Diabetes Care 20:202-207, 1997
16. Jennings PE, McLaren M, Scott NA, Saniabadi AR, Belch JJF: The relationship of oxidative stress to thrombotic tendency in type 1 diabetic patients with retinopathy Diabet Med 8:860-865, 1991
17. Evans RW, Orchard TJ: Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction? Metabolism 43:1196-1200, 1994
18. Halliwell B: Oxidative stress, nutrition and health: experimental strategies for optimization of nutritional antioxidant intakes in humans. Free Rod Biol Med 25:57-74, 1996
19. Chirico S, Smith C, Marchant C, Mitchinson MJ, Halliwell B: Lipid peroxidation in hyperlipidaemic patients: a study of plasma using HPLC-based thiobarbituratic acid test. Free Rad Res Comm 19:51-57, 1993
20. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM, Diabetes 44:1054-1058, 1995
21. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ: Relationships between plasma measures of oxidative stress and metabolic control in non-insulin dependent diabetes mellitus. Diabetologia 40:647-653, 1997
22. Bangstad H-J: Early Diabetic Nephropathy: The Relationship between Blood Glucose Control and Kidney Function and Morphology in Insulin-Dependent Diabetes Mellitus. PhD Thesis. Oslo, Norway, University of Oslo, 1994, p. 1-56
23. Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Nyberg G, Frahm Bjørn S, Hanssen KF: Early glomerulopathy is present in young, type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 36:523-529, 1993
24. Bangstad H-J, Østerby R, Dahl-Jørgensen K, Berg KJ, Hartmann A, Hanssen KF: Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37:483-489, 1994
25. Röschlau P, Bernt E, Gruber W: Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem 12:403-407, 1974
26. Wahlefeld AW: Triglycerides: determination after enzymatic hydrolysis. In Methods of Enzymatic Analysis. Bergmeyer HU, Ed. New York, Academic Press, 1974, p. 1831-1835
27. Friedewald WT, Levy R, Fredrickson DS: Estimations of serum low density lipoprotein cholesterol without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
28. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 220:403-409, 1994
29. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KL, Wolff SP: Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Biochem J 313:781-786, 1996
30. Slater TF, Sawyer BC: The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. Biochem J 123:805-814, 1971
31. Oda A, Bannai C, Yamaoka T, Katori T, Matsushima T, Yamashita K: Inactivation of Cu, Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm Metab Res 26:1-4, 1994
32. Pieper GM, Jordan M, Dondlinger LA, Adams MB, Roza AM: Peroxidative stress in diabetic blood vessels: reversal by pancreatic islet transplantation. Diabetes 44:884-889, 1995
33. Sechi LA, Ceriello A, Griffin CA, Catena C, Amstad P, Schambelan M, Bartoli E: Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus. Diabetologia 40:23-29, 1997
34. Hunt JV Smith CCT, Wolff SP: Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1990
35. Schleicher E, Wagner E, Nerlich AG: Increased accumulation of the glycoxidation product N-(carboxymethyl) lysine in human tissues in diabetes and aging, J Clin Invest 99:457-468, 1997
36. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
37. Zeng, G, Quon MJ: Insulin-stimulated production of nitric oxide is inhibited by Wortmannin: direct measurement in vascular endothelial cells. J Clin Invest 98:894-898, 1996
38. Rubbo H, Radi R. Trujillo M, Telleri R. Kalyanaraman B, Barnes S, Kirk M, Freeman BA: Nitric-oxide regulation of superoxide and peroxynitrite-dependent lipid-peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 268:26066-26075, 1994
39. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, Manto A, Ghirlanda G: Defective plasma antioxidant defences and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46:1853-1858, 1997
40. The Diabetes Control and Complications Trial Research Group: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289-1298, 1996
41. Ghiselli A, Serafini M, Maiani G, Azzini E, Ferroluzzi A: A fluorescence-based method for measuring total plasma antioxidant capability. Free Rad Biol Med 18:29-36, 1995